Knockdown of PD-L1 in mouse renal cell carcinoma inhibits tumor growth and improve the anti-tumor effect of Sunitinib

被引：0
|
作者：
Hara, T. [1 ]
Miyake, H. [2 ]
Fujisawa, M. [1 ]
机构：
[1] Kobe Univ, Kobe, Hyogo, Japan
[2] Hamamatsu Univ, Hamamatsu, Shizuoka, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
438
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [31] Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond
    Zhu, Jason
    Armstrong, Andrew J.
    Friedlander, Terence W.
    Kim, Won
    Pal, Sumanta K.
    George, Daniel J.
    Zhang, Tian
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [32] Bifunctional molecular probe targeting tumor PD-L1 enhances anti-tumor efficacy by promoting ferroptosis in lung cancer mouse model
    Shao, Chenxu
    Yan, Xiaoping
    Pang, Shangjie
    Nian, Di
    Ren, Li
    Li, Hui
    Sun, Junjie
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 130
  • [33] siRNA targeting PD-L1 delivered with attenuated Salmonella enhanced the anti-tumor effect of lenvatinib on mice bearing Hepatocellular carcinoma
    Chen, Pengfei
    Li, Yingjing
    Wei, Pengkun
    Liang, Lirui
    Li, Baozhu
    Cao, Yuhao
    Han, Xinwei
    Wang, Yanling
    Duan, Xuhua
    Jia, Huijie
    Zhao, Tieuso
    Ren, Jianzhuang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 111
  • [34] LYSOSOMAL AUTOPHAGY-BASED DEGRADATION OF HEPATOCELLULAR CARCINOMA PD-L1 MODULATES TUMOR MACROPHAGE POLARIZATION TO ACTIVATE ANTI-TUMOR IMMUNITY
    Gao, Xu
    He, Wangxiao
    Xie, Enrui
    Xing, Zixuan
    Zhang, Yue
    Wang, Jinhai
    Yan, Jin
    Ji, Fanpu
    HEPATOLOGY, 2024, 80 : S2009 - S2010
  • [35] Design, synthesis, anti-tumor activity and mechanism of novel PROTACs as degraders of PD-L1 and inhibitors of PD-1/PD-L1 interaction
    Zhang, Feng
    Yu, Qimeng
    Wu, Caiyun
    Sun, Shishi
    Wang, Yu
    Wang, Rui
    Chen, Zejie
    Zhang, Hua
    Xiong, Xuqiong
    Awadasseid, Annoor
    Rao, Guowu
    Zhao, Xiaoyin
    Zhang, Wen
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 111
  • [36] Dual targeting of TGF-ß and PD-L1 inhibits tumor growth in TGF-ß/PD-L1-driven colorectal carcinoma
    Khalili-Tanha, Ghazaleh
    Fiuji, Hamid
    Gharib, Masoumeh
    Moghbeli, Meysam
    Khalili-Tanha, Nima
    Rahmani, Farzad
    Shakour, Neda
    Maftooh, Mina
    Hassanian, Seyed Mahdi
    Asgharzadeh, Fereshteh
    Shahidsales, Soodabeh
    Anvari, Kazem
    Mozafari, M. R.
    Ferns, Gordon A.
    Batra, Jyotsna
    Giovannetti, Elisa
    Khazaei, Majid
    Avan, Amir
    LIFE SCIENCES, 2023, 328
  • [37] Ferroptosis is involved in the anti-tumor effect of lycorine in renal cell carcinoma cells
    Du, Yang
    Zhao, Hong-Chao
    Zhu, Heng-Cheng
    Jin, Yao
    Wang, Lei
    ONCOLOGY LETTERS, 2021, 22 (05)
  • [38] Targeting the intrinsic signaling of PD-L1 in human monocytes by a novel PD-L1 antibody to promote anti-tumor immunity.
    Hsu, Michelle A.
    Liu, Xin
    Barham, Whitney
    Hirdler, Jacob
    Mao, Zhiming
    Lucien, Fabrice
    Dong, Haidong
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [39] Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
    Munoz, Luis Enrique
    Huang, Lei
    Bommireddy, Ramireddy
    Sharma, Richa
    Monterroza, Lenore
    Guin, Rohini N.
    Samaranayake, Sarah G.
    Pack, Christopher D.
    Ramachandiran, Sampath
    Reddy, Shaker J. C.
    Shanmugam, Mala
    Selvaraj, Periasamy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (11)
  • [40] S-allylmercaptocysteine promotes anti-tumor immunity by suppressing PD-L1 expression
    Zhao, Zhongxi
    Wei, Guangwei
    Zhao, Jianxiong
    Sun, Yueyue
    Gao, Peng
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
12345